Microbubble

Growing Prevalence of Chronic Diseases Propels Global Contrast Media Market to $9.5 Billion by 2029 - ResearchAndMarkets.com

Retrieved on: 
Dienstag, Juni 11, 2024
Medical Devices, Health, Traction, Administration, Stroke, CEUS, Google Images, Prevalence, Agent handling, Procedure, Multiple sclerosis, Iodine, MRI, Mortality, Hospital, Growth, Safety, Conditional sentence, X-ray, DSM-IV codes, Brain, Route of administration, Ultrasound, Investment, Angiography, Disease, Radiation, Medical tourism, Microbubble, Diagnosis, Insurance, Cancer, Contrast (vision), Medical imaging

The global Contrast Media market value stood at US$6.19 billion in 2023 and is expected to reach US$9.5 billion by 2029.

Key Points: 
  • The global Contrast Media market value stood at US$6.19 billion in 2023 and is expected to reach US$9.5 billion by 2029.
  • The global contrast media market is experiencing robust growth due to several key drivers.
  • The growing prevalence of chronic diseases like cancer, cardiovascular conditions, and neurological disorders further fuels the demand for contrast media, as these conditions often necessitate detailed imaging for accurate diagnosis and treatment planning.
  • Moreover, the presence of key market players and continuous technological advancements contribute to North America's dominance in the contrast media market.

Gradiant Launches ForeverGone, the Industry’s Only Complete PFAS Removal and Destruction Solution

Retrieved on: 
Mittwoch, Mai 15, 2024
Engineering, Chemicals, Plastics, Manufacturing, Foam, Transport, PFAS, Water, Incineration, EPA, Electrode, Electrochemistry, Microbubble, Nature, Multimedia, Drinking water, Cosmetics

View the full release here: https://www.businesswire.com/news/home/20240515442694/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240515442694/en/
    Gradiant's ForeverGoneTM is the industry’s only complete all-in-one solution to permanently remove and destroy per- and polyfluoroalkyl substances (PFAS).
  • The Destruction Engine uses electro-oxidation to permanently eliminate the full range of PFAS chemicals from the micro-foamate.
  • The integrated solution achieves comprehensive PFAS removal at the lowest total cost, setting new standards for simplicity, efficiency, and sustainability.
  • The all-in-one PFAS removal and destruction solution is available as standalone containers that can be promptly shipped, installed, and commissioned at customer sites.

Favorable Clinical Data for Applaud Medical’s Novel Technology for Treating Urinary Stones Presented During the 2024 AUA Annual Meeting

Retrieved on: 
Montag, Mai 6, 2024
Biotechnology, Health, Clinical Trials, Other Health, Pain, ELS, Kidney, Safety, American Urological Association, System, MD, BRIO, Fluoroscopy, Patient, Medicine, AUA, Ureter, Trial of the century, Assistant, Standard of care, Annual general meeting, Microbubble, Lithotripsy, Medical imaging

Applaud Medical, an emerging leader in the treatment of urinary stones, today announced positive results from a prospective, multicenter study of the company’s BRIO Enhanced Lithotripsy System (ELS) for the treatment of obstructive ureteral stones.

Key Points: 
  • Applaud Medical, an emerging leader in the treatment of urinary stones, today announced positive results from a prospective, multicenter study of the company’s BRIO Enhanced Lithotripsy System (ELS) for the treatment of obstructive ureteral stones.
  • The results were presented as a podium presentation during the American Urological Association's (AUA) 2024 Annual Meeting held in San Antonio, Texas.
  • The study combined Applaud Medical’s proprietary acoustically enhanced microbubbles with a low-pressure ultrasound system to treat ureteral stones.
  • Our solution aims to eliminate ureteral stones quickly, affordably, and without general anesthesia or fluoroscopy, bringing it to a physician’s office and other non-hospital settings.”

SonoVascular Enters into Strategic Collaboration with Lantheus Holdings, Inc. for Use of Microbubbles in Combination with SonoThrombectomy™ System for Treatment of Venous Thromboembolism

Retrieved on: 
Donnerstag, Mai 2, 2024
Safety, VTE, FIH, Partnership, Pulmonary embolism, Patient, DVT, Catheter, Microbubble, Vein, Coronary thrombosis, Deep vein thrombosis

VTE is a condition that occurs when a blood clot forms in a deep vein, resulting in DVT.

Key Points: 
  • VTE is a condition that occurs when a blood clot forms in a deep vein, resulting in DVT.
  • The microbubbles are activated by intravascular ultrasound and will be investigated in ongoing pre-clinical and upcoming clinical studies.
  • The SonoThrombectomy System has been engineered to address and overcome the deficiencies and limitations of current interventional devices.
  • Additionally, upon completion of a FIH study, SonoVascular has an option to enter into a long-term exclusive commercial supply agreement with Lantheus.

Kohler Co. Showcases Innovation in Design Leadership and Wellness at KBIS 2024

Retrieved on: 
Montag, Februar 26, 2024
Quartz, Acquisition, Filtration, Collection, GxP, Light, Statuesque, Steam, Qingming Festival, Kitchen, Microbubble, Cinq, EPA WaterSense, Calendar, Wave, Kohler Co., Water, KBIS, EPA, Lighting, Vitreous china, Partnership

Guests are encouraged to explore all the latest products throughout the impressive space with a focus on color and design leadership, sustainable living, and wellness.

Key Points: 
  • Guests are encouraged to explore all the latest products throughout the impressive space with a focus on color and design leadership, sustainable living, and wellness.
  • For more than 150 years, Kohler has built a legacy of design leadership through innovation and craftmanship.
  • Wellness brand Sprig by Kohler amplifies the bathing experience, offering clean aromatherapy that infuses the space with soothing botanicals.
  • To learn more about Kohler Co. brands and products, please visit the Kohler KBIS Press Kit.

Kohler Brings Design Leadership and Smart Home Wellness Experiences to CES 2024

Retrieved on: 
Freitag, Januar 5, 2024
Sound, Partnership, Steam, Microbubble, Katalyst, Alexa, Kohler Co., Google Nest (smart speakers), Control, Temperature, Water, Light, Expo Hall, Humidity, Digital technology, CES, Pressure, UV, Consumer electronics

KOHLER, Wis., Jan. 5, 2024 /PRNewswire/ -- Kohler Co. announces its leading-edge designs, innovative new products, and smart home wellness experiences for CES 2024.

Key Points: 
  • KOHLER, Wis., Jan. 5, 2024 /PRNewswire/ -- Kohler Co. announces its leading-edge designs, innovative new products, and smart home wellness experiences for CES 2024.
  • Integration with the Kohler Konnect app provides remote access and control of personalized presets, giving users access to seamless customization from anywhere.
  • Formation 01 defies traditional faucet design and performance and was developed by Kohler in partnership with Dr. Samuel Ross and his industrial design studio SR_A.
  • To learn more about Kohler's CES booth experience and full product lineup, visit the KOHLER CES Press Kit .

Kohler Brings Design Leadership and Smart Home Wellness Experiences to CES 2024

Retrieved on: 
Freitag, Januar 5, 2024
Sound, Partnership, Steam, Microbubble, Katalyst, Alexa, Kohler Co., Google Nest (smart speakers), Control, Temperature, Water, Light, Expo Hall, Humidity, Digital technology, CES, Pressure, UV, Consumer electronics

KOHLER, Wis., Jan. 5, 2024 /PRNewswire/ -- Kohler Co. announces its leading-edge designs, innovative new products, and smart home wellness experiences for CES 2024.

Key Points: 
  • KOHLER, Wis., Jan. 5, 2024 /PRNewswire/ -- Kohler Co. announces its leading-edge designs, innovative new products, and smart home wellness experiences for CES 2024.
  • Integration with the Kohler Konnect app provides remote access and control of personalized presets, giving users access to seamless customization from anywhere.
  • Formation 01 defies traditional faucet design and performance and was developed by Kohler in partnership with Dr. Samuel Ross and his industrial design studio SR_A.
  • To learn more about Kohler's CES booth experience and full product lineup, visit the KOHLER CES Press Kit .

Embrace Exquisite Living with Innovative Personal Care Products at the 134th Canton Fair

Retrieved on: 
Dienstag, Oktober 31, 2023
Shift, Longevity, Phase, Quality of life, Skin, Microbubble, Canton Fair, Multimedia, GLM Co. Ltd., Cosmetics, Nursing care plan, Retail, Online shopping

Guangzhou Xujohn Bio-technique Co., Ltd. presented its Hydrogel Eye Mask at the Canton Fair, a cutting-edge product that embodies their commitment to sustainability.

Key Points: 
  • Guangzhou Xujohn Bio-technique Co., Ltd. presented its Hydrogel Eye Mask at the Canton Fair, a cutting-edge product that embodies their commitment to sustainability.
  • Shanghai Shift Electrics Co., Ltd. brought an array of oral care products to the Canton Fair, where one of their highlights is the smart handheld dental rinser.
  • Personal Care Products showcases a diverse range of innovative products, extending a genuine welcome to buyers worldwide to uncover potential business openings and embrace exquisite living.
  • To gather additional details about the 134th Canton Fair, please visit the official website of the Canton Fair at https://www.cantonfair.org.cn/en-US/posts/646531331412942848 , or contact [email protected] .

Cordance Medical's NeuroAccess Receives FDA Breakthrough Device Designation for Liquid Biopsy in Brain Tumors

Retrieved on: 
Donnerstag, Oktober 26, 2023
Neoplasm, FDA, GBM, Ageing, Food, Washington University in St. Louis, Nucleic acid thermodynamics, Parkinson's disease, Breakthrough, Microbubble, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Glioblastoma, Myenteric plexus, BBB, Blood–brain barrier, DSM-IV codes, Brain, System, Liquid biopsy, Alzheimer's disease, Patient, Diagnosis, DNA, Medical device, Medical imaging, Pharmaceutical industry

MOUNTAIN VIEW, Calif., Oct. 26, 2023 /PRNewswire/ -- Cordance Medical, a pioneering medical device company focused on opening the Blood-Brain Barrier (BBB) to facilitate liquid biopsy, announces that its NeuroAccess™ device has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

Key Points: 
  • MOUNTAIN VIEW, Calif., Oct. 26, 2023 /PRNewswire/ -- Cordance Medical, a pioneering medical device company focused on opening the Blood-Brain Barrier (BBB) to facilitate liquid biopsy, announces that its NeuroAccess™ device has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).
  • The FDA's Breakthrough Device Designation is conferred upon technologies that offer superior treatment or diagnosis for life-threatening or debilitating conditions.
  • "This Breakthrough Device Designation from the FDA is a pivotal milestone for Cordance Medical and for patients requiring more efficacious diagnostic solutions," said Ryan Dittamore, CEO of Cordance Medical.
  • "The Breakthrough Device Designation demonstrates Cordance Medical's commitment to design a safe, patient-centric device for patients with brain diseases," added Dr. Ramamurthy, CTO and co-founder of Cordance Medical.

Global Contrast-Enhanced Ultrasound Market Set to Reach $2.1 Billion by 2028, Driven by Rising Geriatric Population and Research Activities - ResearchAndMarkets.com

Retrieved on: 
Dienstag, September 26, 2023
Medical Devices, Health, Molecule, Equipment, CVD, GE HealthCare, Prevalence, Canon Inc., Bayer, Liver, Diagnosis, Software, Research, USD, Microbubble, Siemens Healthineers, Hospital, Investment, Conditional sentence, Growth, Abdominal ultrasonography, Region, Medical imaging, Pharmaceutical industry, Kidney

The global contrast-enhanced ultrasound market is projected to experience substantial growth, reaching USD 2.1 billion by 2028, up from USD 1.6 billion in 2023, with a CAGR of 6.1% from 2023 to 2028.

Key Points: 
  • The global contrast-enhanced ultrasound market is projected to experience substantial growth, reaching USD 2.1 billion by 2028, up from USD 1.6 billion in 2023, with a CAGR of 6.1% from 2023 to 2028.
  • Key factors driving this growth include the rising geriatric population and increased usage of contrast agents.
  • Additionally, growing research and development activities, government initiatives, and a rising number of clinical trials are contributing to the expansion of the contrast-enhanced ultrasound market.
  • The Asia Pacific region is expected to witness the highest growth in the contrast-enhanced ultrasound market during the forecast period.